| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 9.9% | $333,364 | 280,138 | SABBY MANAGEMENT, LLC | 31 Dec 2025 |
As of 30 Sep 2025, 8 institutional investors reported holding 303,584 shares of InMed Pharmaceuticals Inc. - Common Stock (INM). This represents 11% of the company’s total 2,829,677 outstanding shares.
The largest institutional shareholders of InMed Pharmaceuticals Inc. - Common Stock (INM) together control 11% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 7.8% | 219,998 | 2.5% | $481,796 | |
| DRW Securities, LLC | 1.3% | 35,865 | 0% | $78,544 | |
| Virtu Financial LLC | 0.72% | 20,369 | 0% | $45,000 | |
| RENAISSANCE TECHNOLOGIES LLC | 0.59% | 16,800 | 0% | $36,792 | |
| THOMPSON DAVIS & CO., INC. | 0.36% | 10,249 | 0.01% | $22,445 | |
| SBI Securities Co., Ltd. | 0.01% | 300 | 0% | 0% | $657 |
| Federation des caisses Desjardins du Quebec | 0% | 2 | +100% | 0% | $4 |
| AllSquare Wealth Management LLC | 0% | 1 | 0% | 0% | $2 |
| Banque Cantonale Vaudoise | 0% | 0 | -100% | $0 | |
| Tower Research Capital LLC (TRC) | 0% | 0 | -100% | $0 | |
| UBS Group AG | 0% | 0 | -100% | $0 |